View presentations from the 2017 Neuroendocrine Tumor Patient Regional Meeting
Welcome from Financial Counselor Anne Riley
How should NETs be Classified? Charles M. LeVea, MD, PhD
The Radiologist's Role in NET Management, Charles L. Roche, MD
Carcinoid Syndrome Symptom Control, Hassan Hatoum, MD
Lu177-Dotatate Therapy of NET: Results of the NETTER-1 Study, Jonathan Strosberg, MD
Supplements & Food, Linda Leising, RD, CDN
Patient Stories
HOPE: What Advances Can I Expect in the Next Decade? Renuka Iyer, MD
NET Registry, Renuka Iyer, MD
What is Genomic Profiling? Thorvardur R. Halfdanarson, MD